<DOC>
	<DOCNO>NCT02707692</DOCNO>
	<brief_summary>The purpose study determine impact Pneumococcus Influenza vaccine HIV transcriptional activity individual virologically suppress least 48 week similar ART . The propose study randomize double-blinded control trial conduct 28 week . Randomized intervention injection Influenza vaccine , Pneumococcal vaccine , Placebo . Each participant receive injection randomize order .</brief_summary>
	<brief_title>Perturbing HIV Reservoir With Immune Stimulation</brief_title>
	<detailed_description>Title : Perturbing HIV Reservoir Sample Size : 56 Study Population : HIV-infected individual 18 50 year old start similar antiretroviral therapy ( ART ) chronic infection remain virally suppress least 48 week enrollment . Participants CD4 &gt; 350 cells/μl enrollment CD4 nadir &gt; 200 cells/μl . Participating Sites : UCSD 's Antiviral Research Center ( AVRC ) Study Design : The propose study randomize double-blinded control trial conduct 28 week . Randomized intervention injection Influenza vaccine , Pneumococcal vaccine , Placebo . Each participant receive injection randomize order . Schedule Evaluations : Study evaluation base three 30 day cycle ( Influenza vaccine , Pneumococcus vaccine , Placebo random order ) 28 week RCT . Pre injection : one pair blood genital secretion sample collect injection . Post-injection : pair blood genital secretion sample collect day 2 , 4 , 7 , 14 30 injection . Study Duration : 240 week Study Regimen/Intervention : This double blind RCT two vaccine ( Pneumovax®23 Fluarix® ) plus placebo ( sterile saline injection ) . Study participant follow 28 week enrollment . During 28-week period , blood genital secretion sample collect day 0 five subsequent time point injection ( day 2 , 4 , 7 , 14 30 ) . Injections ( vaccine placebo ) administer 12 week apart random order , minimize possible bias due order vaccine . Primary Objective : To determine impact Pneumococcus Influenza vaccine HIV transcriptional activity individual virologically suppress least 48 week similar ART . Primary Outcome : Average level CD4+ T cell-associated HIV RNA transcription measure day 2 , 4 , 7 , 14 30 injection .</detailed_description>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Documented HIV1 infection ( HIV antibody viral load positive ) . Capable sign write informed consent . Men woman 18 50 year age . Read comprehend English . CD4 count enrollment &gt; 350 cells/ml nadir &gt; 200 cells/ml . Recent vaccination history ( previous year flu vaccination pneumovax least 4 week prior screen visit ) antibody level consistent previous vaccination influenza pneumococcus . Must nonnucleoside reverse transcriptase integrate inhibitor base ART . Uncontrolled psychiatric condition . Under influence drug ( ) alcohol time screen . Any condition , opinion investigator , would limit followup adequate consent . History allergic reaction propose vaccine egg allergy . History Gullian Barre syndrome . Receiving immunosuppressive medication . Pregnancy lactation . Receiving ART regiment contain protease inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Immune Stimulation</keyword>
	<keyword>HIV Reservoir</keyword>
</DOC>